Haviland Kate

Blueprint Medicines Corporation ยท Chief Executive Officer

Haviland Kate is listed in public filings as director, officer: Chief Executive Officer. This Haviland Kate insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Blueprint Medicines Corporation (BPMC), Fulcrum Therapeutics, Inc. (FULC), and Bicara Therapeutics Inc. Common Stock (BCAX). Investors use Haviland Kate's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Blueprint Medicines CorporationBPMC$080k sharesOtherJul 17, 2025$7.6M80k shares$95.12--
Blueprint Medicines CorporationBPMC$070.4k sharesOtherJul 17, 2025$6.8M70.4k shares$96.57--
Blueprint Medicines CorporationBPMC$080k sharesOtherJul 17, 2025$4.9M80k shares$61.31--
Blueprint Medicines CorporationBPMC$080k sharesOtherJul 17, 2025$3.5M80k shares$43.15--
Blueprint Medicines CorporationBPMC$039k sharesOtherJul 17, 2025$3.2M39k shares$81.44--
Blueprint Medicines CorporationBPMC$032.5k sharesOtherJul 17, 2025$2.8M32.5k shares$86.60--
Blueprint Medicines CorporationBPMC$026.1k sharesOtherJul 17, 2025$2.6M26.1k shares$100.13--
Blueprint Medicines CorporationBPMC$028.5k sharesOtherJul 17, 2025$1.5M28.5k shares$54.13--
Blueprint Medicines CorporationBPMC$02 sharesOtherJul 17, 2025$332 shares$16.28--
Blueprint Medicines CorporationBPMC--70.7k sharesOtherJul 17, 2025Disclosure amount unavailable70.7k shares----
Blueprint Medicines CorporationBPMC--70.7k sharesOtherJul 17, 2025Disclosure amount unavailable224.4k shares----
Blueprint Medicines CorporationBPMC--295.1k sharesGrant / ExerciseJul 17, 2025Disclosure amount unavailable129.2k shares----
Blueprint Medicines CorporationBPMC$0591 sharesOtherJul 17, 2025$21.3K591 shares$36.05--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Fulcrum Therapeutics, Inc.FULC$266k36k sharesGrant / ExerciseJun 26, 2025$265.7K36k shares$7.38--
Bicara Therapeutics Inc. Common StockBCAX$273k23.7k sharesGrant / ExerciseJun 9, 2025$272.6K23.7k shares$11.48--
Blueprint Medicines CorporationBPMC$15M166k sharesSellApr 1, 2025$104.8K1.2k shares$87.34--
Blueprint Medicines CorporationBPMC$14M167.2k sharesSellApr 1, 2025$51.5K598 shares$86.14--
Blueprint Medicines CorporationBPMC$14M167.8k sharesSellApr 1, 2025$51.3K600 shares$85.47--
Blueprint Medicines CorporationBPMC$15M165.9k sharesSellApr 1, 2025$8.9K100 shares$88.59--
Blueprint Medicines CorporationBPMC$15M168.4k sharesSellMar 5, 2025$1.4M16.2k shares$88.80--
Blueprint Medicines CorporationBPMC$6.8M70.4k sharesGrant / ExerciseMar 1, 2025$6.8M70.4k shares$96.57--
Blueprint Medicines CorporationBPMC--184.6k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable35.2k shares----
Blueprint Medicines CorporationBPMC$16M149.4k sharesSellJan 21, 2025$159.4K1.4k shares$110.24--
Blueprint Medicines CorporationBPMC$15M151k sharesSellNov 29, 2024$168.9K1.7k shares$96.74--
Blueprint Medicines CorporationBPMC$15M152.8k sharesSellNov 29, 2024$38.2K400 shares$95.40--
Blueprint Medicines CorporationBPMC$15M150.8k sharesSellNov 29, 2024$20.2K207 shares$97.76--
Bicara Therapeutics Inc. Common StockBCAX$427k23.7k sharesGrant / ExerciseSep 12, 2024$427.4K23.7k shares$18.00--
Fulcrum Therapeutics, Inc.FULC$210k30k sharesGrant / ExerciseJun 17, 2024$210.0K30k shares$7.00--